HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Preparation of an MHC Alloy by Direct Doping of HfC and Its High Temperature Oxidation and Volatilization Behavior.

Abstract
An HfC-doped molybdenum (Mo-Hf-C; MHC) alloy was prepared via a powder metallurgy process, including dry direct doping followed by ball-milling, cold-isotactic-pressing, and vacuum sintering. An oxidation comparison experiment was conducted, and the oxidation and volatilization behaviors were analyzed using the mass change, volatile generation rate, and morphology transformation. The results show that relatively uniform powder morphology can be obtained by the direct doping of carbide and high-energy ball milling. The oxidation of the MHC alloy at a lower temperature was characterized by the oxygen-absorption and a slight weight gain, while at a higher temperature and longer holding time, it was characterized by the mass volatile weight loss. A significant weight change appeared at 800 °C for 30 min with a weight loss rate of 4.8%. Surface oxidation products developed horizontally from ridged oxides at lower temperature stages to a flaky oxide layer at higher temperatures. The peeling of the oxide layer was the result of interfacial pore development, which led to exposure of the alloy matrix and further oxidation. Based on the oxidation and volatilization characteristics of HfC-doped MHC alloys, we conclude that the oxidation and volatilization of the MHC alloy conformed to the general law; however, the significant weight loss temperature, weight loss rate, volatilization temperature, and volatilization rate were improved compared with pure molybdenum and traditional molybdenum alloys, thus, indicating that the precipitation of the second phase HfC particles at the grain boundaries and within the grains can inhibit the oxidation and volatilization of matrix elements to a certain extent.
AuthorsMiao Wang, Shuangping Yang, Jie Dong, Haixing Sun, Shouman Liu
JournalMaterials (Basel, Switzerland) (Materials (Basel)) Vol. 15 Issue 5 (03 07 2022) ISSN: 1996-1944 [Print] Switzerland
PMID35269189 (Publication Type: Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: